InVivo to sell shares

InVivo Therapeutics (NVIV -8.9%) intends to offer shares of common stock for public sale pursuant to its shelf registration of January 19, 2012. Underwriter's over-allotment is an additional 15%.

All shares are being offered by the company.

Comments (1)
  • yunkolicious
    , contributor
    Comments (9) | Send Message
    Everyone knew this was imminent so with this announcement now behind us, this should be bullish for this stock. I believe the downward price action since last week means the news was already baked into today's stock price. Hopefully we climb higher from here.
    5 May 2014, 05:03 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs